source
- Women travel abroad for unproven three-parent IVF marketed to older patientsSTAT investigators found that women are journeying thousands of miles to undergo a mitochondrial‑replacement IVF procedure that is promoted as a fertility option for older patients, even though the…
- Top pharma firms line up for Summit Therapeutics' ivonescimab after strong China Phase 3 dataSeveral major biopharma companies, including AstraZeneca, Pfizer and Revolution Medicines, are expressing strong interest in Summit Therapeutics' Akeso-partnered bispecific antibody ivonescimab. Th…